Despite the GAAP EPS miss, the raised full-year guidance and strong VITAS volume growth suggest underlying momentum; however, Roto-Rooter's margin compression from elevated marketing costs may limit near-term upside. Monitor the Q2 call for clarity on sustained profitability trends.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 24 $421.11entry
- T+1 · 7mo ago +0.38%α +0.22% · $422.72
- T+5 · 7mo ago +0.92%α +0.01% · $424.98
- T+20 · 6mo ago +4.85%α +0.83% · $441.55
- T+60 · 4mo ago +19.71%α +14.63% · $504.10
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Chemed Corp. reported Q1 2026 EPS of $4.84 (GAAP) and $5.65 (Adjusted), missing the $5.30 consensus by 6.6%. Revenue rose 1.6% to $657.5M, slightly above estimates. The company raised full-year 2026 adjusted EPS guidance to $24.00–$24.75 (vs. prior $23.25–$24.25), citing strong VITAS performance and share repurchases, while lowering Roto-Rooter EBITDA margin outlook due to higher marketing costs.
Key Financial Metrics
Key Facts
- GAAP EPS of $4.84 missed $5.30 consensus by 8.7%
- Adjusted EPS of $5.65 beat consensus by 6.6%
- Revenue of $657.5M (1.6% YoY growth) slightly above $649.8M estimate
- VITAS revenue up 3.1%, ADC up 2.2%, admissions up 6.9%
- Roto-Rooter revenue down 0.9%, EBITDA margin down 218 bps to 22.5%
- Raised full-year 2026 adjusted EPS guidance to $24.00–$24.75 (midpoint +13% YoY)
- Repurchased 500,000 shares for $197.7M ($395.36/share)
- Entered new $450M credit facility with $313.3M undrawn capacity
Financial Impact
Adjusted EPS guidance raised to $24.00–$24.75, implying ~13% growth over 2025; Roto-Rooter margin pressure from $2M higher marketing spend
Risk Factors
- Roto-Rooter EBITDA margin guidance lowered to 21.5%–22.5% due to persistent marketing spend
- GAAP EPS miss may trigger short-term selling pressure despite adjusted beat
- Concentration risk in VITAS segment with Medicare cap exposure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3280388 |
Track record
19 reports on CHE
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.86% at T+5 after the Oct 27, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago Press Release Neutral 2/10 Entry $528.05 to $548.20 Now $549.45 +4.05% ▲ +3.82% +1.22% vs SPY
- Nov 5, 202611d ago Insider Cluster Bearish 4/10 Entry $533.77 to $550.20 Now $549.45 −2.94% ▼ −3.08% +0.21% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $533.65 to $544.49 Now $549.45 +2.96% ▲ +2.03% +2.62% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
- Oct 27, 202620d ago 8-K Bullish 6/10 No price data
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $512.98 to $534.72 Now $549.45 +7.11% ▲ +4.24% +4.80% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $502.90 to $498.25 Now $549.45 +9.26% ▼ −0.92% −2.23% vs SPY
- Sep 16, 20268w ago Press Release Neutral 4/10 Entry $505.97 to $495.65 Now $549.45 +8.59% ▼ −2.04% −2.64% vs SPY
- Aug 24, 202612w ago Insider Cluster Neutral 3/10 Entry $541.34 to $518.71 Now $549.45 +1.50% ▼ −4.18% −4.65% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers